Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy BioLife Solutions stock

Learn how to easily invest in BioLife Solutions stock.

BioLife Solutions Inc is a medical instruments & supplies business based in the US. BioLife Solutions shares (BLFS) are listed on the NASDAQ and all prices are listed in US Dollars. BioLife Solutions employs 432 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in BioLife Solutions

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – BLFS – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

BioLife Solutions stock price (NASDAQ: BLFS)

Use our graph to track the performance of BLFS stocks over time.

BioLife Solutions shares at a glance

Information last updated 2022-07-03.
Latest market close$14.64
52-week range$10.40 - $60.67
50-day moving average $13.34
200-day moving average $29.02
Wall St. target price$37.13
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.34

Buy BioLife Solutions shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 5 of 5
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
Stocks, ETFs, Cryptocurrency
when you sign up and deposit $100
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, or TN.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you open a Robinhood account
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Axos Bank Self Directed Investing
when you open an account and deposit at least $1500.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy BioLife Solutions stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

BioLife Solutions price performance over time

Historical closes compared with the close of $14.64 from 2022-07-01

1 week (2022-06-28) -0.14%
1 month (2022-06-03) 6.40%
3 months (2022-04-05) -35.79%
6 months (2022-01-05) -55.35%
1 year (2021-07-02) -67.62%
2 years (2020-07-02) -18.58%
3 years (2019-07-05) 15.71
5 years (2017-07-05) 404.83%

Is BioLife Solutions stock undervalued or overvalued?

Valuing BioLife Solutions stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of BioLife Solutions's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

BioLife Solutions's PEG ratio

BioLife Solutions's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 65.3833. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into BioLife Solutions's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

BioLife Solutions financials

Revenue TTM $138.5 million
Gross profit TTM $38.1 million
Return on assets TTM -6.19%
Return on equity TTM -3.95%
Profit margin -9.81%
Book value $11.30
Market capitalisation $620.9 million

TTM: trailing 12 months

BioLife Solutions share dividends

We're not expecting BioLife Solutions to pay a dividend over the next 12 months.

Have BioLife Solutions's shares ever split?

BioLife Solutions's shares were split on a 1:14 basis on 28 January 2014. So if you had owned 14 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your BioLife Solutions shares – just the quantity. However, indirectly, the new 1300% higher share price could have impacted the market appetite for BioLife Solutions shares which in turn could have impacted BioLife Solutions's share price.

BioLife Solutions share price volatility

Over the last 12 months, BioLife Solutions's shares have ranged in value from as little as $10.4 up to $60.67. A popular way to gauge a stock's volatility is its "beta".

BLFS.US volatility(beta: 1.99)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while BioLife Solutions's is 1.9914. This would suggest that BioLife Solutions's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

BioLife Solutions overview

BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; and the ThawSTAR line that includes automated vial and cryobag thawing products that control the heat and timing of the thawing process of biologic materials. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage services. It markets and sells its products directly, as well as through third party distributors. BioLife Solutions, Inc.

Frequently asked questions

What percentage of BioLife Solutions is owned by insiders or institutions?
Currently 7.252% of BioLife Solutions shares are held by insiders and 87.995% by institutions.
How many people work for BioLife Solutions?
Latest data suggests 432 work at BioLife Solutions.
When does the fiscal year end for BioLife Solutions?
BioLife Solutions's fiscal year ends in December.
Where is BioLife Solutions based?
BioLife Solutions's address is: 3303 Monte Villa Parkway, Bothell, WA, United States, 98021
What is BioLife Solutions's ISIN number?
BioLife Solutions's international securities identification number is: US09062W2044
What is BioLife Solutions's CUSIP number?
BioLife Solutions's Committee on Uniform Securities Identification Procedures number is: 09062W105

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site